Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines J Koroth, S Nirgude, S Tiwari, V Gopalakrishnan, R Mahadeva, S Kumar, ... BMC complementary and alternative medicine 19, 1-16, 2019 | 51 | 2019 |
ST09, a novel curcumin derivative, blocks cell migration by inhibiting matrix metalloproteases in breast cancer cells and inhibits tumor progression in EAC mouse tumor models S Nirgude, R Mahadeva, J Koroth, S Kumar, KSS Kumar, ... Molecules 25 (19), 4499, 2020 | 32 | 2020 |
Tuftsin-bearing liposomes co-encapsulated with doxorubicin and curcumin efficiently inhibit EAC tumor growth in mice K Murugesan, P Srinivasan, R Mahadeva, CM Gupta, W Haq International journal of nanomedicine, 10547-10559, 2020 | 14 | 2020 |
ST08 altered NF-κB pathway in breast cancer cells in vitro as revealed by miRNA-mRNA analysis and enhanced the effect of cisplatin on tumour reduction in EAC mouse model S Nirgude, S Desai, R Mahadeva, F Ravindran, B Choudhary Frontiers in Oncology 12, 835027, 2022 | 11 | 2022 |
Curcumin derivative 1, 2-bis [(3E, 5E)-3, 5-bis [(2-chlorophenyl) methylene]-4-oxo-1-piperidyl] ethane-1, 2-dione (ST03) induces mitochondria mediated apoptosis in ovarian … J Koroth, R Mahadeva, F Ravindran, TR Parashar, V Teja, SS Karki, ... Translational Oncology 15 (1), 101280, 2022 | 6 | 2022 |
Znc2 module of RAG1 contributes towards structure-specific nuclease activity of RAGs NM Nilavar, M Nishana, AM Paranjape, R Mahadeva, R Kumari, ... Biochemical Journal 477 (18), 3567-3582, 2020 | 3 | 2020 |
PP053 SP11, a promising coumarin-imidazothiadiazole derivative, targets HSP90 and client proteins to inhibit tumor growth MV Shahana, S Nirgude, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... ESMO Open 8 (1), 2023 | | 2023 |
A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins S Nirgude, MV Shahana, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... Molecules 28 (13), 5226, 2023 | | 2023 |
Curcumin derivative 1, 2-bis ((3E, 5E)-3, 5-bis (4-chlorobenzylidene)-4-oxopiperidine-1-yl) ethane-1, 2-dione hemihydrate, ST09, regulates miR-197-5p/GPX3 axis in breast cancer … S Nirgude, S Desai, F Ravindran, R Mahadeva, S Sharma, J Thumsi, ... | | 2022 |
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor M Manjunath, S Swaroop, SS Pradhan, R Rao K, R Mahadeva, ... Genes 13 (7), 1208, 2022 | | 2022 |